The National Medical Products Administration (NMPA) has released a draft proposal for a “Drug Online Sales Blacklist,” soliciting public feedback. The draft clearly prohibits the online sale of certain high-risk and controlled substances to ensure patient safety and regulatory compliance.
Prohibited Drugs
The draft proposal prohibits the online sale of the following categories of drugs:
- Vaccines
- Blood products
- Narcotic drugs
- Psychotropic drugs
- Toxic drugs for medical use
- Radioactive drugs
- Pharmaceutical precursor chemicals
- Preparations of medical institutions
- Granules of traditional Chinese medicine formula
Additional Restricted Drugs
Other drugs banned from online sales include:
- Injectables (except for hypoglycemic drugs)
- Ephedrine compound preparations and dextromethorphan
- Protein assimilation agents and peptide hormones (except insulin) listed in the Doping List
- 43 high-risk medication varieties, such as digoxin, propafenone, and nemonoxacin
Public Consultation
The NMPA is seeking public feedback on the draft proposal to refine the regulations and ensure they effectively address the risks associated with online drug sales. This initiative underscores the administration’s commitment to safeguarding public health and maintaining strict oversight of pharmaceutical sales channels.-Fineline Info & Tech
